Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel: +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:

Copyright/Disclaimer

New DDDs

Overview of new DDDs decided at the two previous meeting of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the DDDs from the latest meeting (temporary codes) should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDD will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC code	ATC level name (INN/generic name)	DDD	Unit	Adm.route	Deadline for objection to temporary DDDs 1)	Implementation in ATC/DDD index if no objection is received
A07AA11	rifaximin	0.6	g	O	Final	2013
A07AA12	fidaxomicin	0.4	g	O	Final	2013
A10BH05	linagliptin	5	mg	O	01.09.2012	2013
A10BX04	exenatide	0.286	mg	P depot inj	Final	2013
B01AF02	apixaban	5	mg	O	Final	2013
B02BD10	von Willebrand factor	6	TU	P	Final	2013
J01GB01	tobramycin	0.112	g	Inhal. powder	Final	2013
J05AE11	telaprevir	2.25	g	O	Final	2013
J05AE12	boceprevir	2.4	g	O	Final	2013
J05AG02	delavirdine	1.2	g	O	Final	2013
J05AG05	rilpivirine	25	mg	O	01.09.2012	2013
J05AX05	inosine pranobex	3	g	O	Final	2013
L02AE02	leuprorelin	60	mcg	Depot implant	01.09.2012	2013
L02AE04	triptorelin	0.1	mg	P	Final	2013
L02BX03	abiraterone	1	g	O	Final	2013
L03AX14	histamine dihydrochloride	0.5	mg	P	Final	2013
L04AA26	belimumab	25	mg	P	Final	2013
L04AA28	belatacept	12.5	mg	P	Final	2013
L04AX05	pirfenidone	2.4	g	O	01.09.2012	2013
M01AE52	naproxen and esomeprazole	0.5	g ²⁾	O	Final	2013
M05BB06	alendronic acid and alfacalcidol, sequentia	10	mg ³⁾	O	Final	2013
M09AB02	collagenase clostridium histolyticum	0.9	mg	P	Final	2013
N02BG10	nabiximols	42	mg	SL	Final	2013
N03AX21	retigabine	0.9	g	O	Final	2013
N05AD08	droperidol	2.5	mg	P	01.09.2012	2013
N05BA06	lorazepam	2.5	mg	P	Final	2013
N05CM18	dexmedetomidine	1	mg	P	01.09.2012	2013
N06BX18	vinpocetine	15	mg	O	Final	2013
N07XX05	amifampridine	40	mg	O	Final	2013
N07XX59	dextromethorpen, combinations	40	mg ⁴⁾	O	Final	2013
P02CX01	pyrvinium	0.35	g	O	Final	2013
R01AD13	ciclesonide	0.2	mg	N	Final	2013

1) Final: indicates that the date for objection has expired
2) refers to naproxen
3) refers to alendronic acid
4) expressed as dextromethorphan

Last updated: 2012-04-25